CJC-1295 vs Ipamorelin.
These two get sold as a stack so often that people forget they're separate compounds with separate roles. Here's how each one actually works and when running one without the other makes sense.
Same family, same fundamentals.
Both raise endogenous GH output. Both have clean side effect profiles, identical reconstitution math, and identical injection technique. Both are typically dosed in the 100–300 mcg range per shot.
Both keep the pulsatile pattern of GH secretion intact — neither produces a flat elevated GH baseline (well, CJC-1295 with DAC does, but the no-DAC version doesn't). Pulsatile GH is what the body's tissues are calibrated for.
The differences that actually matter.
CJC-1295 is a GHRH analog — it activates the GHRH receptor and tells the pituitary to release a larger GH pulse. Ipamorelin is a ghrelin mimetic — it triggers the pituitary to fire a pulse now. One amplifies, the other triggers. Stacked, the trigger fires a pulse and the amplifier makes that pulse bigger.
Half-life is the practical difference. CJC-1295 without DAC clears in about 30 minutes, so it pairs with ipamorelin (which lasts ~2 hours) — both compounds are circulating during the same pulse. CJC-1295 with DAC stays elevated for 6–8 days, which is a fundamentally different protocol — sustained baseline rather than pulse amplification.
On its own, ipamorelin produces a pulse but doesn't amplify it — the pulse is whatever the pituitary felt like releasing. On its own, CJC-1295 (no DAC) amplifies pulses that are already happening but doesn't trigger extra ones. The stack covers both axes.
Which one fits your goal.
If you can only run one and you want the most bang per shot, run the stack. The two compounds are roughly the same price per dose at the research-peptide tier, and the combined GH output is meaningfully bigger than either alone.
If you want a low-injection protocol — say one shot a week — CJC-1295 with DAC alone is the answer. The long half-life means a single weekly injection keeps GH baseline elevated continuously. Less micromanagement, less pulsatile fidelity to the body's natural rhythm.
If you want multiple GH pulses across the day (morning, post-workout, pre-bed), ipamorelin alone is fine. Each shot triggers a pulse. The amplification CJC-1295 adds is welcome but not essential if your timing is right.
Reconstitute either one in seconds.
Common questions.
Is the CJC-1295 + Ipamorelin stack really that much better than either alone?+
Yes — in research, the combined GH peak is 1.5–2× larger than either compound's peak alone. The mechanisms are designed to compound: triggering plus amplifying. Solo runs of either work, but the stack is the canonical protocol for a reason.
Can I inject CJC-1295 and ipamorelin in the same syringe?+
Yes — they're stable together in solution and many users mix them. Some pre-blended vendor vials exist too. The math: reconstitute each at 5 mg/mL (10 mg / 2 mL), then draw 10 units of each into one syringe — that's 0.1 mL of each, 100 mcg of each, in a single shot.
CJC-1295 with DAC or without?+
Without DAC is the default for the standard pre-bed or post-workout protocol — short half-life means the GHRH amplification is happening during the GH pulse you're targeting. With DAC is a different protocol entirely: 1–2 injections per week, sustained elevated GH baseline. Different tools for different goals.